Cytomx Therapeutics Stock Volatility
| CTMX Stock | USD 0.87 0.02 2.25% |
CytomX Therapeutics secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13% return per unit of risk over the last 3 months. CytomX Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CytomX Therapeutics' Risk Adjusted Performance of (0.09), mean deviation of 2.66, and Standard Deviation of 3.52 to double-check the risk estimate we provide. Key indicators related to CytomX Therapeutics' volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
CytomX Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of CytomX daily returns, and it is calculated using variance and standard deviation. We also use CytomX's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of CytomX Therapeutics volatility.
CytomX |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as CytomX Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of CytomX Therapeutics at lower prices. For example, an investor can purchase CytomX stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of CytomX Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with CytomX Stock
| 0.78 | XFOR | X4 Pharmaceuticals | PairCorr |
| 0.74 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.88 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.81 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
Moving against CytomX Stock
| 0.79 | AMLX | Amylyx Pharmaceuticals | PairCorr |
| 0.7 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.69 | PRAX | Praxis Precision Med | PairCorr |
| 0.67 | AKRO | Akero Therapeutics | PairCorr |
| 0.58 | ALVO | Alvotech | PairCorr |
| 0.54 | CRNX | Crinetics Pharmaceuticals | PairCorr |
| 0.34 | VRDN | Viridian Therapeutics | PairCorr |
CytomX Therapeutics Market Sensitivity And Downside Risk
CytomX Therapeutics' beta coefficient measures the volatility of CytomX stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents CytomX stock's returns against your selected market. In other words, CytomX Therapeutics's beta of 1.18 provides an investor with an approximation of how much risk CytomX Therapeutics stock can potentially add to one of your existing portfolios. CytomX Therapeutics exhibits very low volatility with skewness of 0.66 and kurtosis of 1.69. CytomX Therapeutics is a potential penny stock. Although CytomX Therapeutics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in CytomX Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on CytomX instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze CytomX Therapeutics Demand TrendCheck current 90 days CytomX Therapeutics correlation with market (Dow Jones Industrial)CytomX Beta |
CytomX standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 3.47 |
It is essential to understand the difference between upside risk (as represented by CytomX Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of CytomX Therapeutics' daily returns or price. Since the actual investment returns on holding a position in cytomx stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in CytomX Therapeutics.
CytomX Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which CytomX Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with CytomX Therapeutics' price changes. Investors will then calculate the volatility of CytomX Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of CytomX Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures CytomX Therapeutics' fluctuations based on previous trends. It's commonly used to predict CytomX Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for CytomX Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on CytomX Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. CytomX Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
CytomX Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 1.1792 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, CytomX Therapeutics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CytomX Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CytomX Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CytomX stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
CytomX Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a CytomX Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.CytomX Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of CytomX Therapeutics is -763.07. The daily returns are distributed with a variance of 12.07 and standard deviation of 3.47. The mean deviation of CytomX Therapeutics is currently at 2.58. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.75
α | Alpha over Dow Jones | -0.59 | |
β | Beta against Dow Jones | 1.18 | |
σ | Overall volatility | 3.47 | |
Ir | Information ratio | -0.16 |
CytomX Therapeutics Stock Return Volatility
CytomX Therapeutics historical daily return volatility represents how much of CytomX Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 3.4743% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7608% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About CytomX Therapeutics Volatility
Volatility is a rate at which the price of CytomX Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of CytomX Therapeutics may increase or decrease. In other words, similar to CytomX's beta indicator, it measures the risk of CytomX Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of CytomX Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 131.4 K | 116.8 K | |
| Market Cap | 114.4 M | 108.7 M |
CytomX Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on CytomX Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much CytomX Therapeutics' price varies over time.
3 ways to utilize CytomX Therapeutics' volatility to invest better
Higher CytomX Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of CytomX Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. CytomX Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of CytomX Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in CytomX Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of CytomX Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
CytomX Therapeutics Investment Opportunity
CytomX Therapeutics has a volatility of 3.47 and is 4.57 times more volatile than Dow Jones Industrial. 30 percent of all equities and portfolios are less risky than CytomX Therapeutics. You can use CytomX Therapeutics to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of CytomX Therapeutics to be traded at $0.8352 in 90 days.Modest diversification
The correlation between CytomX Therapeutics and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
CytomX Therapeutics Additional Risk Indicators
The analysis of CytomX Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in CytomX Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of CytomX Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.40) | |||
| Mean Deviation | 2.66 | |||
| Coefficient Of Variation | (742.16) | |||
| Standard Deviation | 3.52 | |||
| Variance | 12.42 | |||
| Information Ratio | (0.16) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
CytomX Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against CytomX Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. CytomX Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, CytomX Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to CytomX Therapeutics.
Additional Tools for CytomX Stock Analysis
When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.